| Managerial & Decision Economics 2007 |
| Title | Subject | Authors |
|---|
| An industrial organization perspective on the influenza vaccine shortage.(Report) | Economics | Scherer, F. M. |
| A primer on the economics of re-importation of prescription drugs.(Report) | Economics | Berndt, Ernst |
| Are they always offering the lowest price? An empirical analysis of the persistence of price dispersion in a low inflation environment.(Report) | Economics | Weiss, Christoph R., Bahadir-Lust, Sebnem, Loy, Jens |
| A sociological view of costs of price adjustment: contributions from grounded theory methods.(Report) | Economics | Zbaracki, Mark J. |
| Asymmetric price adjustment: evidence from weekly product-level scanner price data.(Report) | Economics | Ray, Sourav, Muller, Georg |
| Bank monitoring, managerial ownership and Tobin's Q: An empirical analysis for India.(bank relationships and market value) | Economics | Ghosh, Siabal |
| Bargaining over managerial contracts in delegation games: managerial power, contract disclosure and cartel behavior.(Report) | Economics | van Witteloostuijin, Arjen, Jansen, Thijs, van Lier, Arie |
| Benefits and costs of newer drugs: an update.(Report) | Economics | Lichtenberg, Frank R. |
| 'Branded generics' as a strategy to limit cannibalization of pharmaceutical markets.(Report) | Economics | Reiffen, David, Ward, Michael R. |
| Commentary.(A Primer on the Economics of Re-Importation of Prescription Drugs)(Critical essay) | Economics | Philipson, Tomas J. |
| Commentary: drug and vaccine pricing and innovation, what is the story?(Determinants of Drug Prices and Expenditures)(Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment of Your Health')(An Industrial Organization Perspective on the Influenza Vaccine Shortage)(Critical essay) | Economics | Pauly, Mark V. |
| Commentary.(Dynamic Competition in Pharmaceuticals: Cross-National Evidence from New Drug Diffusion)('Branded Generics' as a Strategy to Limit Cannibalization of Pharmaceutical Markets)(Uncertainty and Choice: The Challenges of Pharmaceutical Efficacy, Safety, and Cost)(Critical essay) | Economics | DiMasi, Joseph A. |
| Commentary.(Entry and Competition in Generic Biologics)(Critical essay) | Economics | Philipson, Tomas J. |
| Commentary.(Product Differentiation, Competition and Regulation of New Drugs: The Case of Statins in Four European Countries)(Critical essay) | Economics | Philipson, Tomas J. |
| Commentary.(The Cost of US Pharmaceutical Price Regulation: A financial Simulation Model of R&D Decisions)(Mergers and Acquisitions in the Pharmaceutical and Biotech Industries)(Effects of Profit-Reducing Policies on Firm Survival, Financial Performance, and New Drug Introductions in the Research-based Pharmaceutical Industry)(Critical essay) | Economics | Golec, Joseph |
| Contests with investment.(Report) | Economics | Munster, Johannes |
| Corporate governance and the returns to acquiring firms shareholders: an international comparison.(Report) | Economics | Mueller, Dennis C., Yurtoglu, B. Burcin |
| Corporate investments and growth options.(Report) | Economics | Reuer, Jeffrey J., Tong, Tony W. |
| Correction of errors in Vetschera's (2004) model of behavioral uncertainty and investment. | Economics | Tularam, G.A., Soomro, A.S. |
| Costly price adjustment and the optimal rate of inflation.(Report) | Economics | Konieczny, Jerzy D. |
| Credible collusion in multimarket oligopoly.(multimarket contact in controlled supply markets) | Economics | Sorenson, Timothy L. |
| Determinants of drug prices and expenditures.(Report) | Economics | Comanor, William S., Schweitzer, Stuart O. |
| Do stable strategic time periods exist? Towards new methodological and theoretical insights. | Economics | Vicente-Lorente, Jose David, Rodriguez-Puerta, Julio, Zuniga-Vicente, Jose Angel, Fuente-Sabate, Juan Manuel de la |
| Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion.(Report)(Graph) | Economics | Danzon, Patricia M., Berndt, Ernst, Kruse, Gregory B. |
| Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry.(Report) | Economics | Filson, Darren, Masia, Neal |
| Efficient organization of information processing.(economic efficiency models) | Economics | Cukrowski, Jacek, Fischer, Manfred M. |
| Entry and competition in generic biologics.(Report) | Economics | Grabowski, Henry G., Schulman, Kevin A., Ridley, David B. |
| Explaining hump-shaped inflation responses to monetary policy shocks.(Report)(Graph) | Economics | Yetman, James |
| Firm governance and duopoly: In weakness may lie strength.(business performance and duopoly markets) | Economics | Brady, Malcolm P. |
| Follow the leader: price change timing in internet-based selling.(Report) | Economics | Kauffman, Robert J., Wood, Charles A. |
| Generic competition and market exclusivity periods.(Report)(Graph) | Economics | Grabowski, Henry G., Kyle, Margaret |
| Hidden monopsony rents in winner-take-all markets-sport and economic contribution of soccer players.(German soccer clubs) | Economics | Garcia-del-Barrio, Pedro, Pujol, Francesc |
| Hierarchical delays as a source of nominal price rigidities: evidence from the microcomputer industry.(Report) | Economics | Hicks, Michael J. |
| If you play well they will come-and vice versa: bidrectional causality in major-league baseball.(sports team performance and audience percentage) | Economics | Horowitz, Ira |
| Investment in organizational capital.(profit optimization methods) | Economics | Gomes, Orlando |
| Managerial expertise, learning potential and dynamic incentives: get more for less? | Economics | Lukas, Christian |
| Mergers and acquisitions in the pharmaceutical and biotech industries.(Report) | Economics | Danzon, Patricia M., Nicholson, Sean, Epstein, Andrew |
| New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003. | Economics | Golec, Joseph, Vernon, John A. |
| New institutional economics' contribution to strategic groups analysis. | Economics | Galvin, Peter, Tywoniak, Stephane, Davies, Jennifer |
| Non-price rigidity and cost of adjustment.(Report) | Economics | Levy, Daniel, Dutta, Shantanu, Bergen, Mark, Muller, Georg |
| Optimal price promotion in the presence of asymmetric reference-price effects.(Report) | Economics | Lowengart, Oded, Gavious, Arieh, Fibich, Gadi |
| Organisational susceptibility to fraud and theft, organizational size and the effectiveness of management controls: some UK evidence. | Economics | Barnes, Paul, Webb, Jill |
| Patterns of corporate governance and technical efficiency in Italian manufacturing. | Economics | Sena, Vania, Destefanis, Serigo |
| Pharmaceutical-embodied technical progress, longevity and quality of life: drugs as 'equipment for your health.'(Report) | Economics | Lichtenberg, Frank R., Virabhak, Suchin |
| Price rigidities, inventories, and growth fluctuations.(Report) | Economics | Tsoukis, Chris, Naqvi, Naveed |
| Price rigidity and market power in German retailing.(Report) | Economics | Weber, Sascha A., Anders, Sven M. |
| Price variability and price dispersion in a stable monetary environment: evidence from German retail markets.(Report) | Economics | Fengler, Matthias R., Winter, Joachim K. |
| Product differentiation, competition and regulation of new drugs: the case of statins in four European countries.(Report) | Economics | McGuire, Alistair, Kanavos, Panos, Font, Joan Costa |
| Production, inventory and waiting time.(Report) | Economics | Epstein, Gil S. |
| Retail prices during a change in monetary regimes: evidence from Sears, Roebuck catalogs, 1938-1951.(Report) | Economics | Young, Andrew T., Blue, Alexander K. |
| Rural Internet access: over-subscription strategies, regulations and equilibrium. | Economics | Shin, S., Weisss, M.B., Tucci, J. |
| Rx Roulette: combatting counterfeit pharmaceuticals in developing nations. | Economics | Lybecker, Kristina M. |
| Small price changes and menu costs.(Report) | Economics | Tsiddon, Daniel, Lach, Saul |
| The cost of biopharmaceutical R&D: is biotech different?(research and development)(Report) | Economics | Grabowski, Henry G., DiMasi, Joseph A. |
| The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions.(Report) | Economics | Abbott, Thomas A., Vernon, John A. |
| The dynamics of daily retail gasoline prices.(Report) | Economics | Davis, Michael C. |
| The frequency and costs of individual price adjustment.(Report) | Economics | Wolman, Alexander L. |
| The frequency and size of price adjustment: microeconomic evidence.(Report) | Economics | Ratfai, Attila |
| The mechanics of price adjustment: new evidence on the (Un)importance of menu costs.(Report) | Economics | Chakrabarti, Rajesh, Scholnick, Barry |
| The real effects of inflation in continuous versus discrete time sticky price models.(Report)(Graph) | Economics | Yetman, James, Ho, Wai-Yip Alex |
| The roles of different types of health insurance on access and utilization: comparative results on two chronic conditions (hypertension and diabetes type II without complication): how patient economic may influence physicians' prescribing decisions.(Report) | Economics | Huttin, Christine |
| The strategic use of managerial incentives in a non-profit firm mixed duopoly.(managerial contracts and mixed duopoly scenarios ) | Economics | Goering, Gregory E. |
| Thick markets, market competition and pricing dynamics: evidence from retailers.(Report) | Economics | Axarloglou, Kostas |
| Trust and formal contracts in interorganizational relationships - substitutes and complements.(Report) | Economics | Mellewigt, Thomas, Madhok, Anoop, Weibel, Antoinette |
| Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost.(Report) | Economics | Scherer, F.M. |
| Why do prices rise faster than they fall? With an application to mortgage rates.(Report) | Economics | Toolsema, Linda A. |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
